Suppr超能文献

2013年至2023年非小细胞肺癌与代谢研究:可视化分析与文献计量学研究

Non-small cell lung cancer and metabolism research from 2013 to 2023: a visual analysis and bibliometric study.

作者信息

Yang Jin, Yang Wei, Zhang Jie, Huang Aiping, Yin Shiyuan, Zhang Hua, Luo Zongrui, Li Xiaojuan, Chen Yihua, Ma Lijie, Wang Chao

机构信息

Department of Pathology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Department of Pathology, General Hospital of Western Theater Command, Chengdu, China.

出版信息

Front Oncol. 2024 May 28;14:1322090. doi: 10.3389/fonc.2024.1322090. eCollection 2024.

Abstract

BACKGROUND

As one of the most prevalent primary lung tumors, non-small cell lung cancer (NSCLC) has garnered considerable research interest due to its high metastasis rates and poor prognosis outcomes. Across different cancer types, metabolic processes are required for tumors progression and growth, thus interfering with such processes in NSCLC may therapeutically viable for limiting/halting disease progression. Therefore, comprehending how metabolic processes contribute to growth and survival mechanisms in cancers, including NSCLC, may elucidate key functions underpinning tumor cell metabolism. However, no bibliometric analyses have been published in this field, therefore we address this knowledge gap here.

METHODS

Between 2013 and 2023 (December 28), articles related to the NSCLC and metabolism (NSCLC-Met) field were retrieved from the Web of Science Core Collection (WoSCC). To fully dissect NSCLC-Met research directions and articles, we used the Bibliometrix package in R, VOSviewer and CiteSpace software to visually represent global trends and hotspots.

RESULTS

Between 2013 and 2023, 2,246 NSCLC-Met articles were retrieved, with a continuous upward trend and rapid development observed year on year. published the most articles, with recording the highest average citation numbers. Zhang Li from China was the most prolific author, but the highest number of authors came from the USA. China, USA, and Italy were the top three countries with the highest number of published articles, with close cooperation identified between countries. Recent hotspots and research directions were reflected by "lung adenocarcinoma", "immunotherapy", "nivolumab", "checkpoint inhibitors", "blockade", and "pembrolizumab", while "gut microbiome", "egfr" and "dose painting" were important topics for researchers.

CONCLUSION

From our analyses, scientists can now explore new hotspots and research directions in the NSCLC-Met field. Further in-depth research in this field will undoubtedly provide more new insights on disease diagnostics, treatment, and prognostics.

摘要

背景

作为最常见的原发性肺癌之一,非小细胞肺癌(NSCLC)因其高转移率和较差的预后结果而引起了广泛的研究关注。在不同类型的癌症中,肿瘤的进展和生长都需要代谢过程,因此干扰NSCLC中的这些过程可能在治疗上对限制/阻止疾病进展可行。因此,了解代谢过程如何促进包括NSCLC在内的癌症的生长和生存机制,可能会阐明肿瘤细胞代谢的关键功能。然而,该领域尚未发表过文献计量分析,因此我们在此填补这一知识空白。

方法

在2013年至2023年(12月28日)期间,从科学网核心合集(WoSCC)中检索与NSCLC和代谢(NSCLC-Met)领域相关的文章。为了全面剖析NSCLC-Met的研究方向和文章,我们使用R语言中的Bibliometrix包、VOSviewer和CiteSpace软件来直观呈现全球趋势和热点。

结果

在2013年至2023年期间,共检索到2246篇NSCLC-Met文章,呈持续上升趋势且逐年快速发展。 发表的文章最多, 记录的平均被引次数最高。中国的张丽是发文量最多的作者,但作者数量最多的国家是美国。中国、美国和意大利是发表文章数量最多的前三个国家,各国之间存在密切合作。“肺腺癌”“免疫疗法”“纳武单抗”“检查点抑制剂”“阻断”和“派姆单抗”反映了近期的热点和研究方向,而“肠道微生物群”“表皮生长因子受体”和“剂量描绘”是研究人员关注的重要主题。

结论

通过我们的分析,科学家现在可以探索NSCLC-Met领域的新热点和研究方向。该领域的进一步深入研究无疑将为疾病的诊断、治疗和预后提供更多新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c15/11165026/8bdca9461db8/fonc-14-1322090-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验